Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Exhibiting at the American Society of Echocardiography 33rd Annual Scientific Session

TheNewsWire June 7, 2022

Ventripoint Announces Sponsorship of the 55th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

TheNewsWire May 17, 2022

Ventripoint Hires Two Strategic Sales Account Managers for US, Europe, and UK Distribution

TheNewsWire May 9, 2022

Ventripoint Announces Sponsorship for the 2022 SickKids Echo Symposium

TheNewsWire May 3, 2022

Ventripoint Welcomes Dr. Jose Banchs as New Clinical Advisor

TheNewsWire April 27, 2022

Ventripoint Welcomes Dr. Howard Michael Leong-Poi as New Clinical Advisor

TheNewsWire April 19, 2022

Ventripoint Signs on AngioConsult/Angiopro as European Distributor

TheNewsWire April 7, 2022

Ventripoint to Exhibit at the American College of Cardiology 71st Annual Scientific Session and Expo and Correction to North Equities Corp Grant of Stock Options

TheNewsWire April 1, 2022

Ventripoint Announces DTC Eligibility Approval in the U.S.

TheNewsWire March 21, 2022

Ventripoint Hires Social Media Firm North Equities Corp.

TheNewsWire March 2, 2022

Ventripoint and at the Mazankowski Heart Institute to Collaborate to Conduct a World-First Study of the Changes in Cardiac Function during Pregnancy

TheNewsWire March 1, 2022

Ventripoint Announces Sponsorship for 24th Annual Canadian Society of Echocardiography Echo Weekend

TheNewsWire February 3, 2022

Ventripoint Appoints Dr. Gregory Skinner to Board of Clinical Advisors

TheNewsWire February 2, 2022

Ventripoint Hires Iconic Investor Relations LLC to Provide Investor Relations Services

TheNewsWire January 27, 2022

Ventripoint Successfully Completes European Commission QMS Certification Surveillance Audit

TheNewsWire January 24, 2022

Ventripoint Issues Option Grants and Reports Exercise of Options and Warrants

TheNewsWire January 21, 2022

Ventripoint Diagnostics (TSXV:VPT) uplists to OTCQB Venture Market

John Ballem  January 7, 2022

Ventripoint Announces Up-Listing to OTCQB Venture Market

TheNewsWire January 7, 2022

Ventripoint Successfully Renews QMS Certification

TheNewsWire December 29, 2021

Ventripoint Expands United Kingdom Marketing with New Distribution Partner CardioLogic

TheNewsWire December 21, 2021